Cargando…
Síntesis de evidencia y recomendaciones: directrices para el tratamiento farmacológico de la hipertensión arterial en adultos
INTRODUCTION. Arterial hypertension (high blood pressure) is one of the most prevalent chronic noncommunicable diseases. It is a cause of cardiovascular disease and is the leading attributable cause of death in the Region of the Americas. OBJECTIVES. Synthesize the recommendations developed by the W...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Organización Panamericana de la Salud
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512685/ https://www.ncbi.nlm.nih.gov/pubmed/36177299 http://dx.doi.org/10.26633/RPSP.2022.172 |
_version_ | 1784797885460643840 |
---|---|
collection | PubMed |
description | INTRODUCTION. Arterial hypertension (high blood pressure) is one of the most prevalent chronic noncommunicable diseases. It is a cause of cardiovascular disease and is the leading attributable cause of death in the Region of the Americas. OBJECTIVES. Synthesize the recommendations developed by the World Health Organization (WHO) to improve the quality of care and health outcomes of adults with high blood pressure, and address aspects of implementing these recommendations. METHODS. A synthesis was conducted of the recommendations contained in the WHO Guideline for the pharmacological treatment of hypertension in adults. In addition, a systematic search for studies carried out in the Region of the Americas was conducted in PubMed, Lilacs, Health Systems Evidence, Epistemonikos, and gray literature in order to identify barriers, facilitators, and implementation strategies. RESULTS. Ten recommendations were made for adults with high blood pressure. Implementation barriers, facilitators, and strategies were identified, and indicators were created for assessing treatment adherence and outcomes. CONCLUSIONS. The formulated recommendations aim to provide guidance on how to approach the pharmacological treatment of hypertension in adults, except pregnant women, as well as considerations for implementation of the recommendations in Latin America and the Caribbean. |
format | Online Article Text |
id | pubmed-9512685 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Organización Panamericana de la Salud |
record_format | MEDLINE/PubMed |
spelling | pubmed-95126852022-09-28 Síntesis de evidencia y recomendaciones: directrices para el tratamiento farmacológico de la hipertensión arterial en adultos Rev Panam Salud Publica Informe Especial INTRODUCTION. Arterial hypertension (high blood pressure) is one of the most prevalent chronic noncommunicable diseases. It is a cause of cardiovascular disease and is the leading attributable cause of death in the Region of the Americas. OBJECTIVES. Synthesize the recommendations developed by the World Health Organization (WHO) to improve the quality of care and health outcomes of adults with high blood pressure, and address aspects of implementing these recommendations. METHODS. A synthesis was conducted of the recommendations contained in the WHO Guideline for the pharmacological treatment of hypertension in adults. In addition, a systematic search for studies carried out in the Region of the Americas was conducted in PubMed, Lilacs, Health Systems Evidence, Epistemonikos, and gray literature in order to identify barriers, facilitators, and implementation strategies. RESULTS. Ten recommendations were made for adults with high blood pressure. Implementation barriers, facilitators, and strategies were identified, and indicators were created for assessing treatment adherence and outcomes. CONCLUSIONS. The formulated recommendations aim to provide guidance on how to approach the pharmacological treatment of hypertension in adults, except pregnant women, as well as considerations for implementation of the recommendations in Latin America and the Caribbean. Organización Panamericana de la Salud 2022-09-26 /pmc/articles/PMC9512685/ /pubmed/36177299 http://dx.doi.org/10.26633/RPSP.2022.172 Text en https://creativecommons.org/licenses/by-nc-nd/3.0/us/Este es un artículo de acceso abierto distribuido bajo los términos de la licencia Creative Commons Attribution-NonCommercial-NoDerivs 3.0 IGO, que permite su uso, distribución y reproducción en cualquier medio, siempre que el trabajo original se cite de la manera adecuada. No se permiten modificaciones a los artículos ni su uso comercial. Al reproducir un artículo no debe haber ningún indicio de que la OPS o el artículo avalan a una organización o un producto específico. El uso del logo de la OPS no está permitido. Esta leyenda debe conservarse, junto con la URL original del artículo. Crédito del logo y texto open access: PLoS, bajo licencia Creative Commons Attribution-Share Alike 3.0 Unported. |
spellingShingle | Informe Especial Síntesis de evidencia y recomendaciones: directrices para el tratamiento farmacológico de la hipertensión arterial en adultos |
title | Síntesis de evidencia y recomendaciones: directrices para el tratamiento farmacológico de la hipertensión arterial en adultos |
title_full | Síntesis de evidencia y recomendaciones: directrices para el tratamiento farmacológico de la hipertensión arterial en adultos |
title_fullStr | Síntesis de evidencia y recomendaciones: directrices para el tratamiento farmacológico de la hipertensión arterial en adultos |
title_full_unstemmed | Síntesis de evidencia y recomendaciones: directrices para el tratamiento farmacológico de la hipertensión arterial en adultos |
title_short | Síntesis de evidencia y recomendaciones: directrices para el tratamiento farmacológico de la hipertensión arterial en adultos |
title_sort | síntesis de evidencia y recomendaciones: directrices para el tratamiento farmacológico de la hipertensión arterial en adultos |
topic | Informe Especial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512685/ https://www.ncbi.nlm.nih.gov/pubmed/36177299 http://dx.doi.org/10.26633/RPSP.2022.172 |
work_keys_str_mv | AT sintesisdeevidenciayrecomendacionesdirectricesparaeltratamientofarmacologicodelahipertensionarterialenadultos |